Breast Cancer

After findings from an early-phase trial showed that the novel drug was associated with anti-tumor activity, investigators decided to continue enrolling more patients with ER-positive, HER2-negative metastatic breast cancer.

Gender be damned, a mother bear’s “fierce compassion” became my default mode as I cared for my ailing adventure partner and soul mate.

From “EastEnders” star Samantha Womack announcing her breast cancer diagnosis in a tribute to Olivia Newton-John to a famous fashion designer’s death from liver cancer, here’s what’s happening in the oncology space this week.

“Love Story,” the story about a young woman who falls in love and then dies of cancer, affects me differently now than it did when I was a teenager and no experience with either love or cancer.

The FDA’s decision to grant the investigational drug elacestrant a priority review for patients with ER-positive, HER2-negative advanced or metastatic breast cancer was based on data that showed the treatment bested standard-of-care in terms of improving survival.

Many patients with breast cancer ask about the benefits of the supplement sulforaphane, but a naturopathic doctor advises patients that it is best to get the compound from food rather than supplements.

Hearing the news of Olivia Newton-John’s death shocked me. I’d loved this lady since the early 70s. But shock wasn’t the only emotion I faced — along with it came overwhelming sadness and fear.

Actress/musician Olivia Newton-John has died after a long bout with breast cancer.

It’s hard to watch other people fight cancer, but I must remember to stay inside my safe zone — my hula hoop — and only run to aid them when they ask.

Although very few patients are informed about the effects that breast cancer treatments may have on their sexual health, many patients expressed wanting that information throughout all stages of their treatment, according to study findings.

I made too many late-night purchases for things that I thought I’d need after my mastectomy. Thankfully, the STOMP group helped me get rid of some of these items.

The Food and Drug Administration approved Enhertu for the treatment of unresectable or metastatic HER2-low breast cancer — marking the first targeted drug for this newly defined breast cancer subtype.

When my grandmother passed, I noticed my aunt was ruder than usual, and I wondered if I was like that during my cancer experience... and if the pain I was going through excused that behavior.

Findings from a recently published study demonstrated that only a small percentage of women — all with breast cancer — who received silicone breast implants underwent the recommended screening to assess for potential ruptures.

Despite how caring they may be, certain people in our life had a difficult time being there for the realities of my daughter’s cancer experience.

The findings add to a growing body of literature that demonstrate coffee and/or tea consumption is not detrimental to breast cancer survivors, according to the study authors.

Losing my hair from breast cancer treatments was an emotional experience for me and helped me empathize with others who also lost their hair.

I felt her authenticity and her genuine care for me. I felt safe.

I was feeling fatigued after undergoing breast cancer treatment, but once I started walking multiple times a week, I noticed that I felt much better.

Drawing helped me stay grounded while my wife was going through cancer treatment.

It baffles me that people take advantage of patients with cancer by peddling fake cures.

Hormone-replacement therapy did not increase chances of death in patients with breast cancer, but certain patient groups may have a higher chance of recurrence from the treatment.

The use of oral paclitaxel and encequidar induced superior outcomes in a group of patients with metastatic breast cancer, compared with paclitaxel delivered intravenously.

Surviving cancer made me thankful for each day. After all, the human lifespan is limited.

If approved, Enhertu may “redefine how we classify and treat metastatic breast cancer,” according to a representative from the drug’s manufacturer.

This year, I returned to the American Society of Clinical Oncology meeting, where I heard about the latest advancements in cancer care, as well as met with fellow patients and advocates.

Investigators are analyzing the novel drug, OP-1250, both as a single-agent treatment option and in combination with Ibrance in patients with recurrent, locally advanced or metastatic ER-positive/HER2-negative breast cancer.

After experiencing complications from breast reconstruction, I’ve decided to go “fabulously flat” and evict my implants.

I would be devastated if my husband left me during my cancer experience. Unfortunately, that is a reality for some people.

At first, I was apprehensive about a male doctor treating my breast cancer, but I soon realized that he was treating me as he would his own family members — and that made me realize that I was in good hands.